Atorvastatin is a pharmaceutical raw material in the production of atorvastatin drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Scope of the Report: This report focuses on the Atorvastatin in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Pfizer DSM Sinochem Pharmaceuticals Ind-Swift Cadila Pharmaceuticals Morepen Sun Pharmaceutical Industries MSN Laboratories Dr. Reddy?s Teva Pharmaceutical Industries Apotex Pharmachem Zheijang Neo-Dankon Pharmaceutical Ningbo Menovo Pharmaceuticals Group Jialin Pharmaceutical Topfond Zhejiang Hisun Pharmacutical Zhejiang Hongyuan Pharmaceutical Hubei Yitai Pharmaceutical Jiangsu Hengrui Medicine. Market Segment by Regions, regional analysis covers Europe (Germany, France, UK, Russia, Italy and Turkey) Middle East (Saudi Arabia, Israel, UAE and Iran) Africa (South Africa, Nigeria, Egypt and Algeria) Market Segment by Type, covers Chemical Synthesis Biocatalysis Market Segment by Applications, can be divided into Tablet (including dispersible tablet and general tablet) Capsule Others There are 13 Chapters to deeply display the EMEA Atorvastatin market. Chapter 1, to describe Atorvastatin Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Atorvastatin, with sales, revenue, and price of Atorvastatin, in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Atorvastatin, for each region, from 2012 to 2017; Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions; Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017; Chapter 10, Atorvastatin market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022; Chapter 11, 12 and 13, to describe Atorvastatin research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source
Table of Contents 1 Market Overview 1.1 Atorvastatin Introduction 1.2 Market Analysis by Type 1.2.1 Chemical Synthesis 1.2.2 Biocatalysis 1.3 Market Analysis by Applications 1.3.1 Tablet (including dispersible tablet and general tablet) 1.3.2 Capsule 1.3.3 Others 1.4 Market Analysis by Regions 1.4.1 Europe (Germany, France,
